ASLONOV I.F. IMPACT OF COMORBID CONDITIONS ON THE DEVELOPMENT OF NEPHROTOXICITY IN PATIENTS RECEIVING ANTI-TUBERCULOSIS THERAPY. Central Asian Journal of Medicine, v. 1, n. 11, p. 240–245, 9 Jan.2026.